EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intestinal Dysmotility and Associated Disorders in Intestinal Muscle of Methylglyoxal‐Treated Mice

Yuki Yamakawa iD, Taiki Mihara iD, Masatoshi Hori

Neurogastroenterology & Motility · 2025

DOI: 10.1111/nmo.70068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurogastroenterology & Motility, 2025. Verfasst von Yuki Yamakawa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Pyruvaldehyde, Gastrointestinal Motility, Muscle, Smooth, Peritoneal Dialysis. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Peritoneal dialysis (PD) is a renal replacement therapy approach to treat end‐stage renal failure. However, complications such as gastrointestinal dysmotility occur in patients undergoing PD, and the mechanisms underlying these complications have not been elucidated. We hypothesized that inflammation and dysfunction of the interstitial cells of Cajal (ICC) contribute to the PD‐induced gastrointestinal dysmotility.

Methods

Mice were intraperitoneally administered a dialysate containing methylglyoxal (40 mM) every other day for 2 weeks to mimic the gastrointestinal complications in patients undergoing long‐term PD. The gastrointestinal transit capacity was evaluated using fluorescent dyes that were forcibly administered orally. To evaluate the inflammation and function of the ICC in the intestinal muscles, we performed real‐time polymerase chain reaction and immunohistochemical staining and measured spontaneous contractions ex vivo. Key Results The intestinal transit capacity was significantly reduced in the methylglyoxal‐treated group compared to that in the control group. In the inflammatory evaluation, the number of neutrophils and macrophages in the intestinal muscles significantly increased in the methylglyoxal‐treated group compared to the control group. Moreover, the mRNA expression levels of Tnf , Il1b , and Il6 were upregulated in the intestinal muscle from the methylglyoxal‐treated group. The mRNA expression of Kit , an interstitial cell of Cajal marker, was significantly decreased in the methylglyoxal‐treated group. In addition, the frequency of spontaneous contractions, an index of ICC function, was decreased in the methylglyoxal‐treated group. Conclusions and Inference Our data suggest that the PD‐induced gastrointestinal dysmotility might be due to inflammation and dysfunction of the ICC in intestinal muscles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyruvaldehydeGastrointestinal MotilityMuscle, SmoothPeritoneal DialysisIntestinesAnimalsMiceInterstitial Cells of CajalMaleMice, Inbred C57BLGastrointestinal TransitInflammation

Stichwörter der Autor:innen

inflammationinterstitial cells of Cajalintestinal transitmethylglyoxalperitoneal dialysis

Substanzen

Pyruvaldehyde

Autor:innen und Institutionen

  • Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Yuki Yamakawa, Taiki Mihara

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Yamakawa, Y., Mihara, T., & Hori, M. (2025). Intestinal Dysmotility and Associated Disorders in Intestinal Muscle of Methylglyoxal‐Treated Mice. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.70068

Vancouver

Yamakawa Y, Mihara T, Hori M. Intestinal Dysmotility and Associated Disorders in Intestinal Muscle of Methylglyoxal‐Treated Mice. Neurogastroenterology & Motility. 2025. doi:10.1111/nmo.70068

BibTeX
@article{Yamakawa2025,
  author = {Yamakawa, Yuki and Mihara, Taiki and Hori, Masatoshi},
  title = {Intestinal Dysmotility and Associated Disorders in Intestinal Muscle of Methylglyoxal‐Treated Mice},
  journal = {Neurogastroenterology & Motility},
  year = {2025},
  doi = {10.1111/nmo.70068}
}
Kostenlos starten →